Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia"

The First Affiliated Hospital of Dalian Medical University, Dalian, China; College of Laboratory Medicine, Dalian Medical University, Dalian
The First Affiliated Hospital of Dalian Medical University, Dalian
The First Affiliated Hospital of Dalian Medical University, Dalian
Haematologica Early view Jul 23, 2026 https://doi.org/10.3324/haematol.2026.301606

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2026.301606
 
Published
2026-07-23
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
97
PDF Downloads
40
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online